FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386443670> ?p ?o ?g. }

• W4386443670 endingPage "13704" @default.
• W4386443670 startingPage "13704" @default.
• W4386443670 abstract "Reactive oxygen species (ROS)-sensitive polymer nanoparticles were synthesized for tumor targeting of an anticancer drug, doxorubicin (DOX). For this purpose, chitosan-methoxy poly(ethylene glycol) (mPEG) (ChitoPEG)-graft copolymer was synthesized and then DOX was conjugated to the backbone of chitosan using a thioketal linker. Subsequently, the chemical structure of the DOX-conjugated ChitoPEG copolymer (ChitoPEGthDOX) was confirmed via 1H nuclear magnetic resonance (NMR) spectra. Nanoparticles of the ChitoPEGthDOX conjugates have spherical shapes and a size of approximately 100 nm. Transmission electron microscopy (TEM) has shown that ChitoPEGthDOX nanoparticles disintegrate in the presence of hydrogen peroxide and the particle size distribution also changes from a monomodal/narrow distribution pattern to a multi-modal/wide distribution pattern. Furthermore, DOX is released faster in the presence of hydrogen peroxide. These results indicated that ChitoPEGthDOX nanoparticles have ROS sensitivity. The anticancer activity of the nanoparticles was evaluated using AT84 oral squamous carcinoma cells. Moreover, DOX-resistant AT84 cells were prepared in vitro. DOX and its nanoparticles showed dose-dependent cytotoxicity in both DOX-sensitive and DOX-resistant AT84 cells in vitro. However, DOX itself showed reduced cytotoxicity against DOX-resistant AT84 cells, while the nanoparticles showed almost similar cytotoxicity to DOX-sensitive and DOX-resistant AT84 cells. This result may be due to the inhibition of intracellular delivery of free DOX, while nanoparticles were efficiently internalized in DOX-resistant cells. The in vivo study of a DOX-resistant AT84 cell-bearing tumor xenograft model showed that nanoparticles have higher antitumor efficacy than those found in free DOX treatment. These results may be related to the efficient accumulation of nanoparticles in the tumor tissue, i.e., the fluorescence intensity in the tumor tissue was stronger than that of any other organs. Our findings suggest that ChitoPEGthDOX nanoparticles may be a promising candidate for ROS-sensitive anticancer delivery against DOX-resistant oral cancer cells." @default.
• W4386443670 created "2023-09-06" @default.
• W4386443670 creator A5023718875 @default.
• W4386443670 creator A5035008501 @default.
• W4386443670 creator A5038375325 @default.
• W4386443670 creator A5053495273 @default.
• W4386443670 creator A5085127606 @default.
• W4386443670 creator A5090421697 @default.
• W4386443670 date "2023-09-05" @default.
• W4386443670 modified "2023-10-17" @default.
• W4386443670 title "Redox-Sensitive Delivery of Doxorubicin from Nanoparticles of Poly(ethylene glycol)-Chitosan Copolymer for Treatment of Drug-Resistant Oral Cancer Cells" @default.
• W4386443670 cites W1837989842 @default.
• W4386443670 cites W1971326454 @default.
• W4386443670 cites W1998959200 @default.
• W4386443670 cites W2051429614 @default.
• W4386443670 cites W2054745605 @default.
• W4386443670 cites W2078057254 @default.
• W4386443670 cites W2085482792 @default.
• W4386443670 cites W2096786319 @default.
• W4386443670 cites W2102785500 @default.
• W4386443670 cites W2109438520 @default.
• W4386443670 cites W2290808044 @default.
• W4386443670 cites W2322116467 @default.
• W4386443670 cites W2418042565 @default.
• W4386443670 cites W2594191206 @default.
• W4386443670 cites W2798161335 @default.
• W4386443670 cites W2807104020 @default.
• W4386443670 cites W2914002249 @default.
• W4386443670 cites W2914772983 @default.
• W4386443670 cites W2966512131 @default.
• W4386443670 cites W2984395468 @default.
• W4386443670 cites W2985345906 @default.
• W4386443670 cites W3016173191 @default.
• W4386443670 cites W3021909056 @default.
• W4386443670 cites W3123368520 @default.
• W4386443670 cites W3138526230 @default.
• W4386443670 cites W3165325129 @default.
• W4386443670 cites W3169556669 @default.
• W4386443670 cites W3214828046 @default.
• W4386443670 cites W4200585405 @default.
• W4386443670 cites W4212832827 @default.
• W4386443670 cites W4220781723 @default.
• W4386443670 cites W4220994023 @default.
• W4386443670 doi "https://doi.org/10.3390/ijms241813704" @default.
• W4386443670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37762003" @default.
• W4386443670 hasPublicationYear "2023" @default.
• W4386443670 type Work @default.
• W4386443670 citedByCount "0" @default.
• W4386443670 crossrefType "journal-article" @default.
• W4386443670 hasAuthorship W4386443670A5023718875 @default.
• W4386443670 hasAuthorship W4386443670A5035008501 @default.
• W4386443670 hasAuthorship W4386443670A5038375325 @default.
• W4386443670 hasAuthorship W4386443670A5053495273 @default.
• W4386443670 hasAuthorship W4386443670A5085127606 @default.
• W4386443670 hasAuthorship W4386443670A5090421697 @default.
• W4386443670 hasBestOaLocation W43864436701 @default.
• W4386443670 hasConcept C109316439 @default.
• W4386443670 hasConcept C12554922 @default.
• W4386443670 hasConcept C13965031 @default.
• W4386443670 hasConcept C141071460 @default.
• W4386443670 hasConcept C155672457 @default.
• W4386443670 hasConcept C171250308 @default.
• W4386443670 hasConcept C178790620 @default.
• W4386443670 hasConcept C185592680 @default.
• W4386443670 hasConcept C192562407 @default.
• W4386443670 hasConcept C202751555 @default.
• W4386443670 hasConcept C2776694085 @default.
• W4386443670 hasConcept C2777516009 @default.
• W4386443670 hasConcept C2779732960 @default.
• W4386443670 hasConcept C2779820397 @default.
• W4386443670 hasConcept C2781303535 @default.
• W4386443670 hasConcept C48349386 @default.
• W4386443670 hasConcept C533411734 @default.
• W4386443670 hasConcept C55493867 @default.
• W4386443670 hasConcept C71924100 @default.
• W4386443670 hasConcept C86803240 @default.
• W4386443670 hasConceptScore W4386443670C109316439 @default.
• W4386443670 hasConceptScore W4386443670C12554922 @default.
• W4386443670 hasConceptScore W4386443670C13965031 @default.
• W4386443670 hasConceptScore W4386443670C141071460 @default.
• W4386443670 hasConceptScore W4386443670C155672457 @default.
• W4386443670 hasConceptScore W4386443670C171250308 @default.
• W4386443670 hasConceptScore W4386443670C178790620 @default.
• W4386443670 hasConceptScore W4386443670C185592680 @default.
• W4386443670 hasConceptScore W4386443670C192562407 @default.
• W4386443670 hasConceptScore W4386443670C202751555 @default.
• W4386443670 hasConceptScore W4386443670C2776694085 @default.
• W4386443670 hasConceptScore W4386443670C2777516009 @default.
• W4386443670 hasConceptScore W4386443670C2779732960 @default.
• W4386443670 hasConceptScore W4386443670C2779820397 @default.
• W4386443670 hasConceptScore W4386443670C2781303535 @default.
• W4386443670 hasConceptScore W4386443670C48349386 @default.
• W4386443670 hasConceptScore W4386443670C533411734 @default.
• W4386443670 hasConceptScore W4386443670C55493867 @default.
• W4386443670 hasConceptScore W4386443670C71924100 @default.
• W4386443670 hasConceptScore W4386443670C86803240 @default.
• W4386443670 hasIssue "18" @default.
• W4386443670 hasLocation W43864436701 @default.

• next